NNC0662-0419 clinical trials
Also written NNC0662-0419.
How each study uses NNC0662-0419 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the NNC0662-0419 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- NNC0662-0419
- 6
Studies by the year they started
6 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4
Studies that test NNC0662-0419.
- Dec 2026A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or ObesityPhase 2 · Novo Nordisk A/S
- May 2027A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body WeightPhase 1 · Novo Nordisk A/S
- Jun 2027A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With ObesityPhase 2 · Novo Nordisk A/S
- Sep 2027A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 DiabetesPhase 2 · Novo Nordisk A/S
Studies
Open first, then newest update. How each study uses NNC0662-0419 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 DiabetesRecruitingPhase 2Novo Nordisk A/SNCT07415954Written as NNC0662-0419
- A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body WeightActive, not recruitingPhase 1Novo Nordisk A/SNCT07525791Written as NNC0662-0419
- A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With ObesityActive, not recruitingPhase 2Novo Nordisk A/SNCT07639021Written as NNC0662-0419
- A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or ObesityActive, not recruitingPhase 2Novo Nordisk A/SNCT07184632Written as NNC0662-0419
- A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT07101783Written as NNC0662-0419
- A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT06737536Written as NNC0662-0419